Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development.

Broadly neutralizing antibodies (bNAbs) are rarely elicited during HIV-1 infection. To identify obstacles to bNAb development, we longitudinally studied 122 rhesus macaques infected by 1 of 16 different simian-human immunodeficiency viruses (SHIVs). We identified the V2 apex region of the envelope (Env) as the most common bNAb target and a subset of Envs that preferentially elicited these antibodies. In 10 macaques, we delineated Env-antibody coevolution from B cell priming to bNAb development. Antibody phylogenies revealed permissive developmental pathways guided by evolving Envs that contained few mutations in or near the V2 apex C-strand, which were a sensitive indicator of apex-targeted responses. The absence of such mutations reflected a failure in bNAb priming. These results indicate that efficiency of B cell priming, and not complexities in Env-guided affinity maturation, is a primary obstacle to V2 apex bNAb elicitation in SHIV-infected macaques and identify specific HIV-1 Envs to advance as vaccine platforms.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-02-13
DOI
https://doi.org/10.1126/sciimmunol.adz3933
Citations
1
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
27.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development.

Jinery Lora, Kasirajan Ayyanathan, Bo Liang, Weimin Liu et al.
1 citations
PubMed
HIV Research and Treatment
27.20
article

Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development.

Jinery Lora, Kasirajan Ayyanathan, Bo Liang, Weimin Liu, Lorie Marchitto, Rumi Habib, Juliette M. Rando, Ashwin N. Skelly, Derek W. Cain, Elizabeth Van Itallie, Andrew Jesse Connell, Ryan S. Roark, Hui Li, Colby J. Agostino, Yong Li, Samantha J. Plante, Neha Chohan, Rohan Roy Chowdhury, Chengyan Zhao, Wilton B. Williams, Ajay Singh, Shuyi Wang, Christian L. Martella, Wenge Ding, Kirsten J. Sowers, Emily E. Lewis, Frédéric Bibollet‐Ruche, Е.В. Голосов, Kevin Wiehe, Zizhang Sheng, Raiees andrabi, Xuduo Li, Younghoon Park, Bette Korber, Kshitij Wagh, Amrit R Ghosh, Barton F Haynes, Mary S Campion, Dennis R Burton, Michael P Hogarty, Facundo D Batista, Beatrice H Hahn, Robert J Edwards, George M Shaw, Daniel W Kulp, John W Carey, Kevin O Saunders, Katharine J Bar, Lawrence Shapiro, Peter D Kwong
article en
1 citations

Abstract

Broadly neutralizing antibodies (bNAbs) are rarely elicited during HIV-1 infection. To identify obstacles to bNAb development, we longitudinally studied 122 rhesus macaques infected by 1 of 16 different simian-human immunodeficiency viruses (SHIVs). We identified the V2 apex region of the envelope (Env) as the most common bNAb target and a subset of Envs that preferentially elicited these antibodies. In 10 macaques, we delineated Env-antibody coevolution from B cell priming to bNAb development. Antibody phylogenies revealed permissive developmental pathways guided by evolving Envs that contained few mutations in or near the V2 apex C-strand, which were a sensitive indicator of apex-targeted responses. The absence of such mutations reflected a failure in bNAb priming. These results indicate that efficiency of B cell priming, and not complexities in Env-guided affinity maturation, is a primary obstacle to V2 apex bNAb elicitation in SHIV-infected macaques and identify specific HIV-1 Envs to advance as vaccine platforms.

PubMedVol. 11(116)
The Wistar Institute (US), Scripps Research Institute (US), Harvard University (US), Aaron Diamond AIDS Research Center (US), Duke University (US), Ragon Institute of MGH, MIT and Harvard (US), Bioqual (US), New Mexico Consortium (US), Massachusetts Institute of Technology (US), Columbia University (US), University of Pennsylvania (US)
Good health and well-being
Openalex Percentile: Top 1%
HIV Research and Treatment
27.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.